Makoto
Payments companies reported to CMS as associated with Makoto. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Makoto, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Makoto
These are the largest totals companies reported as associated with Makoto. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dhananjay Chatterjee | Calabasas, CA | Cardiovascular Disease | $6,120.00 |
| Kyle Reynolds | Washington, DC | Vascular Surgery | $83.43 |
| Micah Girotti | Bel Air, MD | Vascular Surgery | $58.45 |
| Andre Biuckians | Bel Air, MD | Vascular Surgery | $58.44 |
| Jon George | Philadelphia, PA | Interventional Cardiology | $30.00 |
| Yi Zhou | York, PA | Vascular Surgery | $19.92 |
| Grant Scott | Springfield, MO | Vascular Surgery | $15.67 |
| Robert Vorhies | Springfield, MO | Vascular Surgery | $15.67 |
| Eric Secemsky | Boston, MA | Interventional Cardiology | $13.51 |
Prescribed Makoto?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.